Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron and Montelukast in Liver Cirrhosis
NCT07533565Phase 4Completed
- Sponsor
- Kafrelsheikh University
- Start
- Jul 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirabegron, montelukast in overactive bladder (OAB), asthma, sponsored by Kafrelsheikh University. Started Jul 2024; status: completed.
02
Drugs
mirabegronmontelukast
03
Conditions
overactive bladder (OAB)asthma
Beyond the preview
Go deeper on NCT07533565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07533565.